Freelance for Medscape Medical News, Smithsonian.com
Alicia Ault is a freelance writer for Medscape Medical News and Smithsonian.com. She covers a broad range of topics including health, science, medicine, and culture, with a particular focus on the healthcare system, alternative medicine, and wellness. Alicia's work has been featured in various outlets including OBR, Medscape, and MDEdge.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Alicia Ault's articles predominantly cover healthcare and pharmaceutical topics, with a focus on data-driven insights, government announcements, and legal policy regulations. She appears to be particularly interested in articles that cite reliable data sources or that involve government announcements related to the healthcare industry.
As such, she would likely respond well to pitches from experts who can provide analysis or commentary based on credible data sources within the healthcare and pharmaceutical sectors. Additionally, professionals with insights into evolving policies or legal implications relating to drug shortages, mental health issues, medical research advancements, substance abuse treatments and healthcare policies could be valuable contributors for her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
October 10, 2011 | Oncology Practice Author and Disclosure Information
October 7, 2011 | Oncology Practice Author and Disclosure Information FROM AN INSTITUTE OF MEDICINE REPORT
March 7, 2011 | Oncology Practice Author and Disclosure Information
Do patients with early-stage non–small cell lung cancer (NSCLC) benefit from continuing immunotherapy beyond surgery?
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and investigational agents.
A new federal rule could force hospitals and doctors' groups to boost health cybersecurity measures to better protect patients' health information and prevent ransomware attacks.
The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because of the rise of high-potency opioids like fentanyl.
The US Food and Drug Administration (FDA) is urging manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses needed due to the rise of high-potency opioids like fentanyl.
The FDA is proposing a limit on the amount of nicotine in cigarettes and certain other combustible tobacco products to reduce their addictive properties.
The US Food and Drug Administration (FDA) has issued a proposed rule to limit the amount of nicotine in cigarettes and certain other combustible tobacco products in a bid to curb their addictive properties.
(833) 317-6278 
